AVIR
Atea Pharmaceuticals Inc.
$2.93
+$0.05(+1.74%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$235.69M
Volume
267.62K
52W Range
$2.46 - $4.02
Target Price
$6.00
EPS Estimates Overview
| Current Quarter | $-0.46 | Next Quarter | $-0.48 |
| Current Year | $-1.79 | Next Year | $-1.79 |
| QoQ Growth | -4.3% | YoY Growth | +0.0% |
| 3Y EPS CAGR | -49.9% | Target Price | $6.00 |
| Consensus | Buy | Upside | +104.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $2.93 | +1.7% | 267.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW